Atrial Fibrillation (AF) Clinical Trials in Merrillville, Indiana

3 studies are recruiting for atrial fibrillation (af) in Merrillville, Indiana right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

    This study is researching 2 different experimental drugs called REGN7508 and REGN9933 (called "study drugs"). The study is focused on people who have atrial fibrillation, which means that the heart beats too fast and unevenly. When this happens, blood cannot move smoothly through the heart; it can …

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Indiana Medical Research, Merrillville, Indiana
    Locations
    35 in total
    Run by
    Regeneron Pharmaceuticals

    See if you can join NCT07430956 on ClinicalTrials.gov

  2. Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

    This study is researching experimental drugs called REGN7508 and REGN9933. The study is focused on participants who have atrial fibrillation, which means that the heart beats too fast and unevenly. REGN7508 and REGN9933 are designed to help stop blood clots forming in patients with atrial fibrillat…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Indiana Medical Research, Merrillville, Indiana
    Locations
    81 in total
    Run by
    Regeneron Pharmaceuticals

    See if you can join NCT07175428 on ClinicalTrials.gov

  3. Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

    A study to evaluate the effect of abelacimab relative to placebo on the rate of ischemic stroke or systemic embolism (SE) in patients with Atrial Fibrillation (AF) who have been deemed by their responsible physicians or by their own decision to be unsuitable for oral anticoagulation therapy.

    Stage
    Phase 3
    Ages
    65 and older
    Site
    Anthos Investigative Site 1098, Merrillville, Indiana
    Locations
    789 in total
    Run by
    Anthos Therapeutics, Inc.

    See if you can join NCT05712200 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.